APRI vs. CALA, SCPS, EVLO, ARDS, STAB, CMRA, AMPE, EFTR, MTEM, and ONCSQ
Should you be buying Apricus Biosciences stock or one of its competitors? The main competitors of Apricus Biosciences include Calithera Biosciences (CALA), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Comera Life Sciences (CMRA), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), Molecular Templates (MTEM), and OncoSec Medical (ONCSQ). These companies are all part of the "medical" sector.
Apricus Biosciences vs.
Calithera Biosciences (NASDAQ:CALA) and Apricus Biosciences (NASDAQ:APRI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends.
19.9% of Apricus Biosciences shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by company insiders. Comparatively, 2.3% of Apricus Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Calithera Biosciences' return on equity of 0.00% beat Apricus Biosciences' return on equity.
Calithera Biosciences received 111 more outperform votes than Apricus Biosciences when rated by MarketBeat users. However, 69.91% of users gave Apricus Biosciences an outperform vote while only 55.36% of users gave Calithera Biosciences an outperform vote.
Calithera Biosciences has a beta of -1.13, indicating that its share price is 213% less volatile than the S&P 500. Comparatively, Apricus Biosciences has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.
In the previous week, Calithera Biosciences had 1 more articles in the media than Apricus Biosciences. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Apricus Biosciences. Calithera Biosciences' average media sentiment score of 0.00 equaled Apricus Biosciences'average media sentiment score.
Apricus Biosciences has higher revenue and earnings than Calithera Biosciences.
Summary
Calithera Biosciences and Apricus Biosciences tied by winning 5 of the 10 factors compared between the two stocks.
Get Apricus Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APRI and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Apricus Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:APRI) was last updated on 5/3/2025 by MarketBeat.com Staff
Buy APRI Stock Free APRI Stock Alerts